• Report Description
  • Table Of Content
  • Request Methodology

Global Platelet-rich Plasma Market, 2018-2023, is a market research report by KD Market Insights that offers extensive and highly detailed current and future market trends in the global and regional/market. The report offers market size and structure of the overall industry based upon a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise. Global Platelet-rich Plasma Market was held at USD XXX Million in 2017 and is expected to garner USD XXX Million by the end of 2023.

The market research report demonstrates market dynamics including growth drivers, barriers and opportunities and trends spearheading current nature and future status of this market. The report is supplemented with various indicators which are believed to propel the growth of the market during the forecast period.

In Addition, Porter’s Five Forces analysis demonstrates the five forces i.e. buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in Platelet-rich Plasma Market. The report also offers value chain analysis for the Platelet-rich Plasma Market.

Global Platelet-rich Plasma Market Size & Forecast
The report reviews the preliminary estimates for 2018 and forecasts for growth in Platelet-rich Plasma Market demand for 2019-2023. It analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

The report segments the market based on By Type into…

- Pure Platelet-rich Plasma
- Leukocyte-rich Platelet-rich Plasma
- Pure Platelet-rich Fibrin

Further, the market has been also segmented By Origin into…

- Autologous Platelet-rich Plasma
- Allogeneic Platelet-rich Plasma
- Homologous Platelet-rich Plasma

Further, the market has been also segmented By Application into…

- Orthopedic Surgery
- Neurosurgery
- Cosmetic Surgery
- General Surgery
- Others

Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Platelet-rich Plasma Market: Competitive Landscape
The report also highlights the competitive landscape of the global Platelet-rich Plasma Market, positioning of all the major players in industry. Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, risk analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development expansion and other market activities.

The research study includes profiles of leading companies operating in the global Platelet-rich Plasma Market.

Some of the Key Players profiled include:

- Harvest Technologies Corp. (Terumo Corporation)
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- EmCyte Corporation
- Regen Lab SA
- Exactech, Inc.,
- Cesca Therapeutics, Inc.
- Nuo Therapeutics, Inc.
- DePuy Synthes (Johnson & Johnson)
- ISTO Biologics
- AdiStem Ltd.
- Other Major & Niche Key Players

Research Methodology
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Platelet-rich Plasma Market
3. Global Platelet-rich Plasma Market Trends
4. Opportunities in Global Platelet-rich Plasma Market
5. Recent Industry Activities, 2017
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Platelet-rich Plasma Market Size (USD Million), Growth Analysis and Forecast, (2017-2023)

9. Global Platelet-rich Plasma Market Segmentation Analysis, By Type
9.1. Introduction
9.2. Market Attractiveness, By Type
9.3. BPS Analysis, By Type
9.4. Pure Platelet-rich Plasma
9.5. Leukocyte-rich Platelet-rich Plasma
9.6. Pure Platelet-rich Fibrin

10. Global Platelet-rich Plasma Market Segmentation Analysis, By Origin
10.1. Introduction
10.2. Market Attractiveness, By Origin
10.3. BPS Analysis, By Origin
10.4. Autologous Platelet-rich Plasma
10.5. Allogeneic Platelet-rich Plasma
10.6. Homologous Platelet-rich Plasma

11. Global Platelet-rich Plasma Market Segmentation Analysis, By Application
11.1. Introduction
11.2. Market Attractiveness, By Application
11.3. BPS Analysis, By Application
11.4. Orthopedic Surgery
11.5. Neurosurgery
11.6. Cosmetic Surgery
11.7. General Surgery
11.8. Others

12. Geographical Analysis
12.1. Introduction
12.2. North America Platelet-rich Plasma Market Size (USD Million) & Volume, 2017-2023
12.2.1. By Type
12.2.2. By Origin
12.2.3. By Application
12.2.4. By Country
12.2.4.1. Market Attractiveness, By End-user
12.2.4.2. BPS Analysis, By End-User
12.2.4.3. U.S. Market Size (USD Million) 2017-2023
12.2.4.4. Canada Market Size (USD Million 2017-2023

12.3. Europe Platelet-rich Plasma Market Size (USD Million) & Volume, 2017-2023
12.3.1. By Type
12.3.2. By Origin
12.3.3. By Application
12.3.4. By Country
12.3.4.1. Market Attractiveness, By Country
12.3.4.2. BPS Analysis, By Country
12.3.4.3. Germany Market Size (USD Million) 2017-2023
12.3.4.4. United Kingdom Market Size (USD Million) 2017-2023
12.3.4.5. France Market Size (USD Million) 2017-2023
12.3.4.6. Italy Market Size (USD Million) 2017-2023
12.3.4.7. Spain Market Size (USD Million) 2017-2023
12.3.4.8. Russia Market Size (USD Million) 2017-2023
12.3.4.9. Rest of Europe Market Size (USD Million) 2017-2023

12.4. Asia Pacific Platelet-rich Plasma Market Size (USD Million), 2017-2023
12.4.1. By Type
12.4.2. By Origin
12.4.3. By Application
12.4.4. By Country
12.4.4.1. Market Attractiveness, By Country
12.4.4.2. BPS Analysis, By Country
12.4.4.3. China Market Size (USD Million) 2017-2023
12.4.4.4. India Market Size (USD Million) 2017-2023
12.4.4.5. Japan Market Size (USD Million) 2017-2023
12.4.4.6. South Korea Market Size (USD Million) 2017-2023
12.4.4.7. Indonesia Market Size (USD Million) 2017-2023
12.4.4.8. Taiwan Market Size (USD Million) 2017-2023
12.4.4.9. Australia Market Size (USD Million) 2017-2023
12.4.4.10. New Zealand Market Size (USD Million, 2017-2023
12.4.4.11. Rest of Asia Pacific Market Size (USD Million) 2017-2023

12.5. Latin America Platelet-rich Plasma Market Size (USD Million) 2017-2023
12.5.1. By Type
12.5.2. By Origin
12.5.3. By Application
12.5.4. By Country
12.5.4.1. Market Attractiveness, By Country
12.5.4.2. BPS Analysis, By Country
12.5.4.3. Brazil Market Size (USD Million) 2017-2023
12.5.4.4. Mexico Market Size (USD Million) 2017-2023
12.5.4.5. Rest of Latin America Market Size (USD Million, 2017-2023

12.6. Middle East & Africa Platelet-rich Plasma Market Size (USD Million) 2017-2023
12.6.1. By Type
12.6.2. By Origin
12.6.3. By Application
12.6.4. By Geography
12.6.4.1. Market Attractiveness, By Geography
12.6.4.2. BPS Analysis, By Geography
12.6.4.3. GCC Market Size (USD Million) 2017-2023
12.6.4.4. North Africa Market Size (USD Million) 2017-2023
12.6.4.5. South Africa Market Size (USD Million) 2017-2023
12.6.4.6. Rest of Middle East & Africa Market Size (USD Million) 2017-2023

13. Competitive Landscape
13.1. Market Share of Key Players
13.2. Market Positioning of Major Players in Global Platelet-rich Plasma Market
13.3. Company Profiles
13.3.1. Harvest Technologies Corp. (Terumo Corporation)
13.3.1.1. Product Offered
13.3.1.2. Business Strategy
13.3.1.3. Financials
13.3.1.4. SWOT Analysis
13.3.1.5. Market Share Analysis
13.3.1.6. Key Achievements & Developments
13.3.2. Arthrex, Inc.
13.3.3. Zimmer Biomet Holdings, Inc.
13.3.4. EmCyte Corporation
13.3.5. Regen Lab SA
13.3.6. Exactech, Inc.,
13.3.7. Cesca Therapeutics, Inc.
13.3.8. Nuo Therapeutics, Inc.
13.3.9. DePuy Synthes (Johnson & Johnson)
13.3.10. ISTO Biologics
13.3.11. AdiStem Ltd.
13.3.12. Other Major & Niche Key Players

Select License Type
  • Single User License $3330 USD
  • Multi-User License $4230 USD
  • Corporate User License $5130 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients